Hormone Therapy, Dilemmas, Medical Decisions |
| |
| Authors: | Jay Schulkin |
| |
| Affiliation: | Currently the Director of Research at the American College of Obstetricians and Gynecologists, and is also affiliated with the Department of Physiology and Biophysics and Neuroscience School of Medicine at Georgetown University as well as the Neuroimaging in Mood and Anxiety Disorders Section of the National Institute of Mental Health. |
| |
| Abstract: | The decision for women to go on hormone therapy (HT) remains controversial. An historical oscillation of beliefs exists related in part to expectations of the medicinal value of HT over longer-term use beyond the initial peri-menonpausal period. Studies thought to resolve issues surrounding the efficacy of HT were perhaps overstated as confusion still permeates the decision making with regard to HT. Overzealous advertising and exaggerated understanding of the results (negative or positive) undermine patient and physician decision making. There remains no magic bullet with regard to HT. What remains is still the possibility of HT longer-term efficacy on diverse end organ systems with pockets of clinical and scientific ambiguity while working to engender reasonable expectations. |
| |
| Keywords: | |
|
|
